Drug Profile
F 390
Alternative Names: Nidulalin ALatest Information Update: 01 Oct 2004
Price :
$50
*
At a glance
- Originator Ajinomoto
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Oct 2004 Discontinued - Preclinical for Cancer in Japan (unspecified route)
- 24 Jun 2001 No-Development-Reported for Cancer in Japan (Unknown route)
- 03 Jul 1997 Preclinical development for Cancer in Japan (Unknown route)